Treatment of In-Stent restenosis using a stent with non-polymer-based paclitaxel elution

Rainer Hoffmann; Roswitha Langenberg; Peter Radke; Harald Kühl; Jan Ortlepp; Rüdiger Blindt; Eberhard Grube

doi:10.1016/j.amjcard.2003.12.006

Treatment of In-Stent restenosis using a stent with non-polymer-based paclitaxel elution

Am J Cardiol. 2004 Mar 15;93(6):760-2. doi: 10.1016/j.amjcard.2003.12.006.

Authors

Rainer Hoffmann¹, Roswitha Langenberg, Peter Radke, Harald Kühl, Jan Ortlepp, Rüdiger Blindt, Eberhard Grube

Affiliation

¹ Medical Clinic I, University Aachen, Aachen, Germany. [email protected]

PMID: 15019887
DOI: 10.1016/j.amjcard.2003.12.006

Abstract

Treatment of in-stent restenosis remains a therapeutic challenge. Twenty-seven lesions with in-stent restenosis were treated with non-polymer-based paclitaxel-eluting stents. At 6-month follow-up, in-stent late loss was 0.44 +/- 0.54 mm and the restenosis rate was 20%, indicating effective treatment for reduction of recurrent restenosis.

Publication types

Clinical Trial
Multicenter Study

MeSH terms

Coronary Angiography
Coronary Restenosis* / diagnostic imaging
Coronary Restenosis* / pathology
Coronary Restenosis* / therapy*
Europe
Female
Growth Inhibitors / administration & dosage*
Humans
Male
Middle Aged
Paclitaxel / administration & dosage*
Polymers
Stents*
Treatment Outcome

Substances

Growth Inhibitors
Polymers
Paclitaxel